In this context, the effects of combining an allosteric positive modulator such as EC-21a or GAT229 with an inhibitor for FAAH or MAGL also deserve to be investigated for a comprehensive approach to the treatment of neurodegenerative diseases. The gene discussed is MGLL; the disease is neurodegenerative disease.